Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large B-Cell, Diffuse trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1/2 Country / region: Spain Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20151
20161
20182
20193
20202
20212
20223
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Terminated5
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab3
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
ADC Therapeutics S.A.1
BeOne Medicines1
Bristol-Myers Squibb1
Celgene1
CytomX Therapeutics1
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse20
Lymphoma, Non-Hodgkin6
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Follicular5
Lymphoma, Mantle-Cell4
Burkitt Lymphoma3
Lymphoma, B-Cell3
Multiple Myeloma3
Neoplasms3
Recurrence3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.